Showing results (31-40 of 156) with videos related to
Sort By:
Pageof 16
Journal of Leukocyte Biology|July 15, 2009
Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccineLarissa Herkenhoff Haut, Hildegund C J ErtlHybridoma and Hybridomics|May 29, 2002
Rabies vaccines: from the past to the 21st centuryAndreas R Kammer, Hildegund C J ErtlHuman Gene Therapy|January 3, 2017
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving ControversyHildegund C J Ertl, Katherine A HighThe Journal of Biological Chemistry|April 18, 1997
Leptin impairs metabolic actions of insulin in isolated rat adipocytesG Müller, J Ertl, M Gerl, et al.Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Vaccine Design: Replication-Defective Adenovirus VectorsXiangyang Zhou, Zhiquan Xiang, Hildegund C J ErtlBioorganic & Medicinal Chemistry|November 5, 2002
Synthesis, conformation and T-helper cell stimulation of an O-linked glycopeptide epitope containing extended carbohydrate side-chainsMare Cudic, Hildegund C J Ertl, Laszlo OtvosVirology|October 18, 2005
DNA immunization using a non-viral promoterT Vanniasinkam, S T Reddy, H C J ErtlScandinavian Journal of Immunology|September 18, 2002
An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53M Blaszczyk-Thurin, I O Ertl, H C J ErtlVaccine|August 30, 2018
New human rabies vaccines in the pipelineAnthony R Fooks, Ashley C Banyard, Hildegund C J ErtlCellular Immunology|November 12, 2003
Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virusA R Pinto, A Reyes-Sandoval, H C J ErtlPageof 16